Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00052598
Status:
TERMINATED
Last Update Posted:
2017-02-15
First Post:
2003-01-24
Brief Title:
Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-09
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2003-01-24
First Submit QC Date:
January 26 2003
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2017-02-13
Disp First Submit QC Date:
February 13 2017
Disp First Post Date:
2017-02-15
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2017-02-13
Last Update Post Date:
2017-02-15
Last Update Post Date Type:
ACTUAL